NZX50 slides to nine-month low

NZX50 slides to nine-month low
A new drug has weighed on Fisher and Paykel's shares. (Image: Getty)
Graham Skellern
A weight-reducing drug is causing trouble for Fisher and Paykel Healthcare as the New Zealand sharemarket chalked up its sixth successive fall.The S&P/NZX 50 Index was on a downward slide all day and closed at 11,344.11, down 82.73 points or 0.72% – its lowest level for nine months.The index has now fallen 1.8% for the year and was at 11308.31 points on November 28.There were 42 gainers and 84 decliners on the main board, with 28.19 million shares worth $102.5m changing hands.Under pressureMarket heavyweight Fisher and Paykel Healthca...

More Markets

NZ sharemarket down over 1.5% for the week
Markets Market close

NZ sharemarket down over 1.5% for the week

The S&P/NZX 50 Index closed at 12,559.28, down 79.62 points or 0.63%.

Graham Skellern 01 Nov 2024
Just Life Group sells The Cylinder Guy
Markets

Just Life Group sells The Cylinder Guy

Just Life Group CEO says it was probably a mistake buying the business in 2020.

John Anthony 01 Nov 2024
Spark board mum on future of dividend, asset sales
Finance

Spark board mum on future of dividend, asset sales

Shareholders will have to wait until company's half-year results to learn more.

Ben Moore 01 Nov 2024
Vulcan Steel looks forward to better times
Markets

Vulcan Steel looks forward to better times

The newer aluminium operations are outperforming steel.

Greg Hurrell 01 Nov 2024